GENE ONLINE|News &
Opinion
Blog

Asthma
China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma
2024-08-21
Asthma Medications: From Quick Relief to Long-Term Control
2024-03-11
GSK Completed the Acquisition of Aiolos Bio, Enhancing the Respiratory Portfolio of Asthma
2024-02-16
AstraZeneca’s severe asthma drug Tezspire has been granted market authorization in South Korea
2023-12-25
Have A Good Night’s Sleep To Cut Asthma Risk
2023-04-17
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
Can Your Smartwatch Help You Manage Asthma Better?
2020-09-19
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
Astra Zeneca to Resume Rivalry with Old Competitor Following Key Win for FASENRA®
2019-10-14
Novartis Reports Trial Successes of its Asthma Drugs that Holds Potential Edge Over Longstanding Market Leader
2019-10-04
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
LATEST
China Develops Longevity Labs and Immortality Islands in National Anti-Aging Initiative
2025-11-08
Ferroptosis Identified as Key Factor in Diabetic Wound Healing Challenges
2025-11-08
Study Identifies Mental Health Disorders and Economic Hardship as Key Factors in Filicide Cases
2025-11-07
Study Finds Mobility Patterns Reveal Hidden Air Pollution Disparities in Boston
2025-11-07
Study Explores Impact of Early Walking Experiences on Locomotor Exploration in Preterm Infants
2025-11-07
Study Explores Ovarian MicroRNA Changes in Macrobrachium rosenbergii Following Eyestalk Ablation
2025-11-07
Study Finds Medical Students in the US Using AI Tools for Personalized Learning and Diagnostic Simulations
2025-11-07
EVENT
Scroll to Top